Peritoneal dialysis (PD) is a successful dialysis modality that enables patients with end-stage
kidney disease to have a home-based treatment with many advantages for their quality of …

Cardiovascular disease contributes significantly to the adverse clinical outcomes of peritoneal
dialysis (PD) patients. Numerous cardiovascular risk factors play important roles in the …

… “I’d be more interested in the paper that tells me about life participation because I think
that more holistically covers what I’m more interested in about my life.” [G1, patient] …

The worldwide burden of kidney disease is rising, but public awareness remains limited,
underscoring the need for more effective communication by stakeholders in the kidney health …

Fibrosis in response to tissue damage or persistent inflammation is a pathological hallmark
of many chronic degenerative diseases. By using a model of acute peritoneal inflammation, …

Systemic inflammation, as evidenced by elevated inflammatory cytokines, is a feature of
advanced renal failure and predicts worse survival. Dialysate IL-6 concentrations associate with …

The kinetics of circulating cell-free DNA (cfDNA) release may provide a real-time assessment
of induced cell death. However, there is a limited understanding of the underlying …

Home dialysis modalities (home hemodialysis [HD] and peritoneal dialysis [PD]) are
associated with greater patient autonomy and treatment satisfaction compared with in-center …

Background Extending technique survival on peritoneal dialysis (PD) remains a major
challenge in optimizing outcomes for PD patients while increasing PD utilization. The primary …

Background Variability in ultrafiltration influences prescriptions and outcomes in patients
with kidney failure who are treated with peritoneal dialysis. Variants in AQP1, the gene that …